BRUNSWICK CORP (BC) Fundamental Analysis & Valuation

NYSE:BC • US1170431092

Current stock price

70.47 USD
-0.71 (-1%)
At close:
70.47 USD
0 (0%)
After Hours:

This BC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BC Profitability Analysis

1.1 Basic Checks

  • In the past year BC was profitable.
  • BC had a positive operating cash flow in the past year.
  • Of the past 5 years BC 4 years were profitable.
  • In the past 5 years BC always reported a positive cash flow from operatings.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • BC's Return On Assets of -2.58% is in line compared to the rest of the industry. BC outperforms 40.63% of its industry peers.
  • BC's Return On Equity of -8.45% is in line compared to the rest of the industry. BC outperforms 40.63% of its industry peers.
  • BC has a better Return On Invested Capital (5.91%) than 65.63% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BC is in line with the industry average of 7.45%.
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROIC 5.91%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • BC has a better Operating Margin (5.83%) than 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of BC has declined.
  • BC's Gross Margin of 24.84% is on the low side compared to the rest of the industry. BC is outperformed by 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of BC has declined.
Industry RankSector Rank
OM 5.83%
PM (TTM) N/A
GM 24.84%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y-2.03%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BC is creating some value.
  • Compared to 1 year ago, BC has less shares outstanding
  • BC has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BC has an improved debt to assets ratio.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • BC has an Altman-Z score of 2.98. This is not the best score and indicates that BC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • BC has a better Altman-Z score (2.98) than 62.50% of its industry peers.
  • BC has a debt to FCF ratio of 5.30. This is a neutral value as BC would need 5.30 years to pay back of all of its debts.
  • The Debt to FCF ratio of BC (5.30) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.11 is on the high side and indicates that BC has dependencies on debt financing.
  • BC has a worse Debt to Equity ratio (1.11) than 65.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Altman-Z 2.98
ROIC/WACC0.68
WACC8.68%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • BC has a Current Ratio of 1.44. This is a normal value and indicates that BC is financially healthy and should not expect problems in meeting its short term obligations.
  • BC has a worse Current ratio (1.44) than 65.63% of its industry peers.
  • BC has a Quick Ratio of 1.44. This is a bad value and indicates that BC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.61, BC is doing worse than 71.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.61
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BC Growth Analysis

3.1 Past

  • The earnings per share for BC have decreased strongly by -28.29% in the last year.
  • BC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.40% yearly.
  • BC shows a small growth in Revenue. In the last year, the Revenue has grown by 2.40%.
  • Measured over the past years, BC shows a small growth in Revenue. The Revenue has been growing by 4.29% on average per year.
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.86% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 5.76% on average over the next years.
EPS Next Y33.56%
EPS Next 2Y28.22%
EPS Next 3Y27.67%
EPS Next 5Y27.86%
Revenue Next Year9.08%
Revenue Next 2Y7.1%
Revenue Next 3Y6.73%
Revenue Next 5Y5.76%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

6

4. BC Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 21.55 indicates a rather expensive valuation of BC.
  • 68.75% of the companies in the same industry are more expensive than BC, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, BC is valued at the same level.
  • BC is valuated correctly with a Price/Forward Earnings ratio of 16.14.
  • Based on the Price/Forward Earnings ratio, BC is valued a bit cheaper than 68.75% of the companies in the same industry.
  • BC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.42.
Industry RankSector Rank
PE 21.55
Fwd PE 16.14
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BC is valued a bit cheaper than the industry average as 65.63% of the companies are valued more expensively.
  • 81.25% of the companies in the same industry are more expensive than BC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.53
EV/EBITDA 10.6
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BC's earnings are expected to grow with 27.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2Y28.22%
EPS Next 3Y27.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. BC Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.47%, BC has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.28, BC pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, BC pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.47%

5.2 History

  • The dividend of BC is nicely growing with an annual growth rate of 11.59%!
  • BC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • BC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.59%
Div Incr Years12
Div Non Decr Years16
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • BC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • BC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-82.01%
EPS Next 2Y28.22%
EPS Next 3Y27.67%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

More info and screens

Find the best dividend stocksShow peers with best dividend

BC Fundamentals: All Metrics, Ratios and Statistics

BRUNSWICK CORP

NYSE:BC (3/20/2026, 8:04:00 PM)

After market: 70.47 0 (0%)

70.47

-0.71 (-1%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners104.78%
Inst Owner Change-6.26%
Ins Owners0.93%
Ins Owner Change0.11%
Market Cap4.57B
Revenue(TTM)5.36B
Net Income(TTM)-137.30M
Analysts76.43
Price Target90.25 (28.07%)
Short Float %5.89%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield 2.47%
Yearly Dividend1.72
Dividend Growth(5Y)11.59%
DP-82.01%
Div Incr Years12
Div Non Decr Years16
Ex-Date02-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.15%
Min EPS beat(2)-2.34%
Max EPS beat(2)10.64%
EPS beat(4)3
Avg EPS beat(4)41.04%
Min EPS beat(4)-2.34%
Max EPS beat(4)136.9%
EPS beat(8)4
Avg EPS beat(8)19.7%
EPS beat(12)5
Avg EPS beat(12)11.6%
EPS beat(16)7
Avg EPS beat(16)8.89%
Revenue beat(2)2
Avg Revenue beat(2)5.84%
Min Revenue beat(2)4.71%
Max Revenue beat(2)6.96%
Revenue beat(4)4
Avg Revenue beat(4)7.35%
Min Revenue beat(4)4.71%
Max Revenue beat(4)12.87%
Revenue beat(8)5
Avg Revenue beat(8)2.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)6
Avg Revenue beat(16)-1.2%
PT rev (1m)0.4%
PT rev (3m)16.32%
EPS NQ rev (1m)-5.48%
EPS NQ rev (3m)-40.86%
EPS NY rev (1m)0.33%
EPS NY rev (3m)2.32%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)3.46%
Valuation
Industry RankSector Rank
PE 21.55
Fwd PE 16.14
P/S 0.85
P/FCF 11.53
P/OCF 8.13
P/B 2.81
P/tB 51
EV/EBITDA 10.6
EPS(TTM)3.27
EY4.64%
EPS(NY)4.37
Fwd EY6.2%
FCF(TTM)6.11
FCFY8.67%
OCF(TTM)8.67
OCFY12.3%
SpS82.7
BVpS25.07
TBVpS1.38
PEG (NY)0.64
PEG (5Y)N/A
Graham Number42.95
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -8.45%
ROCE 8.04%
ROIC 5.91%
ROICexc 6.33%
ROICexgc 10.98%
OM 5.83%
PM (TTM) N/A
GM 24.84%
FCFM 7.39%
ROA(3y)2.15%
ROA(5y)5.62%
ROE(3y)6.19%
ROE(5y)16.54%
ROIC(3y)8.7%
ROIC(5y)11.18%
ROICexc(3y)9.5%
ROICexc(5y)12.37%
ROICexgc(3y)18.05%
ROICexgc(5y)24.22%
ROCE(3y)11.84%
ROCE(5y)15.22%
ROICexgc growth 3Y-29.65%
ROICexgc growth 5Y-20.68%
ROICexc growth 3Y-27.91%
ROICexc growth 5Y-19.68%
OM growth 3Y-25.84%
OM growth 5Y-14.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.01%
GM growth 5Y-2.03%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.3
Debt/EBITDA 2.99
Cap/Depr 56.68%
Cap/Sales 3.09%
Interest Coverage 2.72
Cash Conversion 92.92%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.61
Altman-Z 2.98
F-Score5
WACC8.68%
ROIC/WACC0.68
Cap/Depr(3y)73.55%
Cap/Depr(5y)107.72%
Cap/Sales(3y)3.6%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.29%
EPS 3Y-31.13%
EPS 5Y-8.4%
EPS Q2Q%141.67%
EPS Next Y33.56%
EPS Next 2Y28.22%
EPS Next 3Y27.67%
EPS Next 5Y27.86%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y-7.66%
Revenue growth 5Y4.29%
Sales Q2Q%15.49%
Revenue Next Year9.08%
Revenue Next 2Y7.1%
Revenue Next 3Y6.73%
Revenue Next 5Y5.76%
EBIT growth 1Y-27.9%
EBIT growth 3Y-31.52%
EBIT growth 5Y-10.54%
EBIT Next Year84.19%
EBIT Next 3Y32.29%
EBIT Next 5Y23.77%
FCF growth 1Y50.11%
FCF growth 3Y26.07%
FCF growth 5Y-8.44%
OCF growth 1Y30.3%
OCF growth 3Y-1.38%
OCF growth 5Y-6.78%

BRUNSWICK CORP / BC Fundamental Analysis FAQ

What is the fundamental rating for BC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BC.


What is the valuation status of BRUNSWICK CORP (BC) stock?

ChartMill assigns a valuation rating of 6 / 10 to BRUNSWICK CORP (BC). This can be considered as Fairly Valued.


How profitable is BRUNSWICK CORP (BC) stock?

BRUNSWICK CORP (BC) has a profitability rating of 4 / 10.


What is the valuation of BRUNSWICK CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRUNSWICK CORP (BC) is 21.55 and the Price/Book (PB) ratio is 2.81.


What is the financial health of BRUNSWICK CORP (BC) stock?

The financial health rating of BRUNSWICK CORP (BC) is 3 / 10.